Clinical Trials Directory

Trials / Completed

CompletedNCT06202157

Metabolic Differences Between Dihydroberberine and Micellar Berberine

Metabolic Differences Between Dihydroberberine and Micellar Berberine in Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Factors Group of Nutritional Companies Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

Differences in metabolites of dihydroberberine (DHB) and micellar berberine (LipoMicel®, LMB) are investigated through a randomized study involving human volunteers. Over a 24-hour period, blood samples are collected and subjected to Ultra High-Performance Liquid Chromatography-High Resolution Mass Spectrometry (UHPLC-HRMS) analysis to quantify the concentrations of berberine and its metabolites.

Conditions

Interventions

TypeNameDescription
OTHERLMBA baseline blood sample (t=0) is collected from each participant prior to the intervention (LMB), and subsequent blood samples are collected at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours post-intervention.
OTHERDHBA baseline blood sample (t=0) is collected from each participant prior to the intervention (DHB), and subsequent blood samples are collected at 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours post-intervention.

Timeline

Start date
2023-04-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2024-01-11
Last updated
2024-01-11

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06202157. Inclusion in this directory is not an endorsement.